Clinical trial
Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal…
NCT00035178 · Texas Biotechnology Corporation, Industry · Completed
Key facts
| NCT number | NCT00035178 |
|---|---|
| Title | Pharmacokinetics/Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease Patients Undergoing Hemodialysis |
| Official title | Pharmacokinetics and Pharmacodynamics of Argatroban Injection in End-Stage Renal Disease (ESRD) Patients Undergoing Hemodialysis |
| Lead sponsor | Texas Biotechnology Corporation, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Kidney Failure, Chronic, Renal Disease, End-Stage |
| Intervention type | Drug |
| Interventions | Argatroban |
| Enrollment | 12 |
| Start date | May 1, 2002 |
| Completion | Nov 1, 2002 |
| First posted | May 3, 2002 |
| Last update posted | Jun 24, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: